new_0222_0361|VINC|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0361|VINC|1|Vincerx Pharma Inc Total Current Assets (Quarterly) (USD)|Vincerx Pharma Inc Cash and Short Term Investments (Quarterly) (USD)|Vincerx Pharma Inc Inventories (Quarterly) (USD)|Vincerx Pharma Inc Net PP&E (Quarterly) (USD)|Vincerx Pharma Inc Goodwill and Intangibles (Quarterly) (USD)|Vincerx Pharma Inc Total Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Current Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Long Term Liabilities (Quarterly) (USD)|Vincerx Pharma Inc Total Deposits (Quarterly) (USD)|Vincerx Pharma Inc Book Value (Quarterly) (USD)|Vincerx Pharma Inc Retained Earnings (Quarterly) (USD)|Vincerx Pharma Inc Treasury Stock (Quarterly) (USD)|Vincerx Pharma Inc EV to Revenues|Vincerx Pharma Inc EV to Earnings|Vincerx Pharma Inc EV to Free Cash Flow|Vincerx Pharma Inc EV to Assets (Quarterly)|Vincerx Pharma Inc PS Ratio|Vincerx Pharma Inc PE Ratio|Vincerx Pharma Inc Price to Book Value|Vincerx Pharma Inc PEG Ratio|Vincerx Pharma Inc Debt to Equity Ratio|Vincerx Pharma Inc Dividend Yield|Vincerx Pharma Inc Shareholder Yield (TTM)|Vincerx Pharma Inc Percent of Shares Outstanding Short|Vincerx Pharma Inc Total Receivables (Quarterly) (USD)|Vincerx Pharma Inc Total Payables (Quarterly) (USD)|Vincerx Pharma Inc Total Capital Stock (Quarterly) (USD)|Vincerx Pharma Inc Return on Invested Capital|Vincerx Pharma Inc Quality Ratio Score|Vincerx Pharma Inc Momentum Score|Vincerx Pharma Inc Beta (1Y)|Vincerx Pharma Inc Sustainable Growth Rate (TTM)|Vincerx Pharma Inc Institutional Investor Ownership Percentage|Vincerx Pharma Inc Average Diluted Shares Outstanding (Quarterly)|Vincerx Pharma Inc Total Employees (Annual)|Vincerx Pharma Inc EPS Diluted (Quarterly) (USD)|Vincerx Pharma Inc SG&A Expense (Quarterly) (USD)|Vincerx Pharma Inc Shares Outstanding|Vincerx Pharma Inc Repurchase of Capital Stock (Quarterly) (USD)|Vincerx Pharma Inc Ordinary Shares Number (Quarterly)|Vincerx Pharma Inc Payout Ratio|Vincerx Pharma Inc Quick Ratio (Quarterly)|Vincerx Pharma Inc Normalized Diluted EPS (Quarterly) (USD)|Vincerx Pharma Inc Stock Buybacks (Quarterly) (USD)|Vincerx Pharma Inc Effective Tax Rate (TTM)|Vincerx Pharma Inc Return on Equity|Vincerx Pharma Inc Net Income (TTM) (USD)|Vincerx Pharma Inc Revenue (TTM) (USD)|Vincerx Pharma Inc Dividend Per Share (Quarterly) (USD)|Vincerx Pharma Inc Revenue (Quarterly) (USD)|Vincerx Pharma Inc Gross Profit (Quarterly) (USD)|Vincerx Pharma Inc Pre-Tax Income (Quarterly) (USD)|Vincerx Pharma Inc Net Income (Quarterly) (USD)|Vincerx Pharma Inc Net Interest Income (Quarterly) (USD)|Vincerx Pharma Inc Price (USD)|Vincerx Pharma Inc Total Return Price (USD)|Vincerx Pharma Inc Enterprise Value (USD)|Vincerx Pharma Inc 30-Day Average Daily Volume|Vincerx Pharma Inc 1 Year Price Returns (Daily)|Vincerx Pharma Inc Short Interest|Vincerx Pharma Inc PE Ratio (Forward)|Vincerx Pharma Inc PE Ratio (Forward 1y)|Vincerx Pharma Inc PS Ratio (Forward)|Vincerx Pharma Inc PS Ratio (Forward 1y)|Vincerx Pharma Inc Quarterly EPS Estimates (USD)|Vincerx Pharma Inc Quarterly Revenue Estimates (USD)|Vincerx Pharma Inc Quarterly EPS Surprise|Vincerx Pharma Inc Quarterly Revenue Surprise|Vincerx Pharma Inc Quarterly Actual EPS (USD)|Vincerx Pharma Inc Quarterly Actual Revenue (USD)|Vincerx Pharma Inc Revenue Estimates for Current Fiscal Year (USD)|Vincerx Pharma Inc Revenue Estimates for Next Fiscal Year (USD)|Vincerx Pharma Inc Price Target (USD)|Vincerx Pharma Inc Consensus Recommendation|Vincerx Pharma Inc Price Target Num Estimates|Vincerx Pharma Inc EPS Estimates for Current Fiscal Year (USD)|Vincerx Pharma Inc EPS Estimates for Next Fiscal Year (USD)|Vincerx Pharma Inc Research and Development Expense (Quarterly) (USD)|Vincerx Pharma Inc Reconciled Depreciation (Quarterly) (USD)|Vincerx Pharma Inc Non-Operating Interest Expense (Quarterly) (USD)|Vincerx Pharma Inc Land and Improvements (Quarterly) (USD)|Vincerx Pharma Inc Buildings and Improvements (Quarterly) (USD)|Vincerx Pharma Inc Other Properties (Quarterly) (USD)|Vincerx Pharma Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0361|VINC|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0361|VINC|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0361|VINC|5|91.25|91.25||91.5||91.25|91.25|91.25||91.25|91.25||||1.44755244755||||1.44755244755|||1.44292237443||15.2307692308||91.25|91.25|||30.7142857143|30.625||30.4615384615|91.3333333333||91.3333333333|91.3333333333|25.9166666667||91.25|||91.3333333333|91.25|||91|||||91.3333333333|91.3333333333||1.44292237443|1.44292237443|1.45172413793|1.44254278729|1.44324324324|15.2307692308|||||91.4285714286|91.4|91.5||91.5||37.9|53.2857142857|26.6428571429|19.380952381|26.6428571429|23.6875|24.8666666667|91.3333333333|91.3333333333||||91.5|||
new_0222_0361|VINC|6|4|4||2||4|4|4||4|4||||286||||286|||438||26||4|4|||7|8||13|6||6|6|12||4|||6|4|||3|||||6|6||438|438|290|409|185|26|||||7|5|2||2||10|7|14|21|14|16|15|6|6||||2|||
new_0222_0361|VINC|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0361|VINC|202003||||||||||||||||||||||||||||||||||5.076||-0.0008|0.004||||||-0.0008|||||||||-0.004|-0.004||10.69|10.69||||||||||||||||||||||||||||||
new_0222_0361|VINC|202006||||||||||||||||||||||||||||||||||5.009||-0.01|0.033||||||-0.01|||||||||-0.033|-0.033||9.96|9.96||4802.4|||||||||||||||||||||||||||10.135|10.05
new_0222_0361|VINC|202009|0.4755|0.0363||||0.8594|0.6575|0.2019||-0.3839|-0.3886|||||||||||||||0.6575|0.001|||||||5.076||-0.06|0.305|||13.9844|||-0.06|||||||||-0.307|-0.307||12.4|12.4||36360.8667|||||||||||||||||||||||||||15.48|16.5
new_0222_0361|VINC|202012|63.11|61.792||||37.813|37.813|||25.379|-16.665||||-101.1943||||11.5219|||||0.2506||5.505|0.001||||||37.1218|5.954|28|-3.09|3.256|13.9844||13.9844|||-3.09||||-16.62|||||-16.276|-16.276||20.91|20.91|230.6218|19970.2667||35046|||||||||||||33|1|2|-0.09|-1.88|7.116|||||||19.09|19.3
new_0222_0361|VINC|202103|54.408|53.355||3.372||32.447|29.171|3.276||25.553|-22.941||||-40.2862||||11.0997|||||4.2322||0.461|0.001||||-0.9636||84.7213|13.735||-0.46|4.791|14.6959||14.6959|||-0.7038||||-22.892|||||-6.276|-6.276||19.3|19.3|230.2759|132335.3667|48.4492|621965|||||-0.3||-53.3333||-0.46||||33|1|2|-1.24|-1.82|4.834|-0.025||||3.372||16|13.88
new_0222_0361|VINC|202106|86.505|85.623||4.445||19.542|15.684|3.858||71.595|-24.975||||-10.2207||||3.179|||||4.3485||1.83|0.001|||4|-0.9853||85.1902|16.35||-0.12|6.695|17.5211||17.5211|||-1.0594||||-24.893|||||-2.034|-2.034||12.99|12.99|141.9761|176690.1|30.4217|761912|||||-0.3||60||-0.12||||29.6667|1|3|-2.66|-2.875|10.698|-0.026||||4.445||13.25|15.68
new_0222_0361|VINC|202109|123.248|122.796||4.419||28.799|25.162|3.637||100.626|-49.499||||-9.0273||||3.378|||||5.8986||2.259|0.002|||7|-0.1905||80.8027|17.694||-1.39|5.72|21.0211||21.0211|||-1.0167|-47.499|||-49.11|||||-24.524|-24.524||16.17|16.17|217.1152|179149.5333|30.4032|1239959|||||-0.8525||-18.827||-1.013||||29.75|1.25|4|-2.7025|-3.2667|12.211|0.048||||4.419||13.97|10.49
new_0222_0361|VINC|202112|||||||||||||||-3.8006||||2.1287|||||3.9467||||||2|-0.1192||81.9681||||||||||||||||||||||10.19|10.19|91.409|93510.4667|-51.2673|831080|||||-1.0029||||||||27.5|1.1667|6|-3.1743|-3.2183||||||||7.19|5.99
new_0222_0361|VINC|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.905|||||||||||||||||||||
new_0222_0361|VINC|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.95|||||||||||||||||||||
new_0222_0361|VINC|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.995|||||||||||||||||||||
new_0222_0361|VINC|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.965|||||||||||||||||||||